Whitehawk Therapeutics (WHWK) Amortization of Deferred Charges (2016 - 2024)
Whitehawk Therapeutics' (WHWK) quarterly Amortization of Deferred Charges came in at -$38000.0 in Q4 2024, down 90.0% on a QoQ basis from -$20000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) Amortization of Deferred Charges (2016 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 7 years of Amortization of Deferred Charges data on file, last reported at -$38000.0 in Q4 2024.
- On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to -$38000.0 in Q4 2024; TTM through Sep 2025 was -$38000.0, a 200.0% decrease from a year earlier, with the FY2023 full-year figure at $58000.0, changed N/A from the prior year.
- Amortization of Deferred Charges for Q4 2024 stood at -$38000.0, down from -$20000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for WHWK reached as high as $230000.0 in Q4 2020 and fell as low as -$584000.0 in Q4 2021.
- Historically, Amortization of Deferred Charges has averaged $24000.0 across 5 years, with a median of $58000.0 in 2022.
- Across the five-year window, Amortization of Deferred Charges tumbled 353.91% in 2021 and changed 0.0% in 2023, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $230000.0 in 2020, then slumped by 353.91% to -$584000.0 in 2021, then surged by 80.31% to -$115000.0 in 2022, then soared by 150.43% to $58000.0 in 2023, then plunged by 165.52% to -$38000.0 in 2024.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were -$38000.0 in Q4 2024, -$20000.0 in Q3 2024, and $58000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Sep 30, 2024 | -20,000.00 |
| Sep 30, 2024 | -20,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Sep 30, 2022 | -115,000.00 |
| Sep 30, 2022 | -115,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | -584,000.00 |
| Dec 31, 2021 | -584,000.00 |
| Sep 30, 2021 | 133,000.00 |
| Sep 30, 2021 | 133,000.00 |
| Jun 30, 2021 | 227,000.00 |
| Jun 30, 2021 | 227,000.00 |